Brief: Scancell Signs Agreement With Biotech Co To Evaluate Antibody In Glymab® Portfolio

Scancell Holdings

12/06/2024 07:57

June 12 (Reuters) - Scancell Holdings PLC  SCLP.L :
    * SCANCELL HLDS  - AGREEMENT WITH MAJOR BIOTECH
    * SCANCELL HOLDINGS PLC: SIGNS AGREEMENT WITH INTERNATIONAL
BIOTECHNOLOGY COMPANY TO EVALUATE AN ANTIBODY IN GLYMAB®
PORTFOLIO

Source text for Eikon:  ID:nRSL1151Sa 
Further company coverage:  SCLP.L 

 ((Reuters.Briefs@thomsonreuters.com;;))